95.23 - 97.14
55.47 - 103.81
1.63M / 1.80M (Avg.)
55.57 | 1.74
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
47.14%
Revenue growth above 1.5x AEM's 19.76%. David Dodd would confirm if the firm has a unique advantage driving sales higher.
70.16%
Gross profit growth above 1.5x AEM's 35.33%. David Dodd would confirm if the company's business model is superior in terms of production costs or pricing.
78.16%
Positive EBIT growth while AEM is negative. John Neff might see a substantial edge in operational management.
78.16%
Positive operating income growth while AEM is negative. John Neff might view this as a competitive edge in operations.
96.62%
Net income growth under 50% of AEM's 218.00%. Michael Burry would suspect the firm is falling well behind a key competitor.
84.21%
EPS growth under 50% of AEM's 218.18%. Michael Burry would suspect deeper structural issues or share dilution limiting per-share gains.
105.88%
Diluted EPS growth at 50-75% of AEM's 209.09%. Martin Whitman would question if share issuance or modest net income gains hamper progress.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
81.11%
Positive OCF growth while AEM is negative. John Neff would see this as a clear operational advantage vs. the competitor.
-3124.58%
Both companies show negative FCF growth. Martin Whitman would consider an industry-wide capital spending surge or margin compression.
81.04%
Similar 10Y revenue/share CAGR to AEM's 88.70%. Walter Schloss might see both firms benefiting from the same long-term demand.
36841732.28%
5Y revenue/share CAGR above 1.5x AEM's 131.13%. David Dodd would look for consistent product or market expansions fueling outperformance.
59.87%
3Y revenue/share CAGR under 50% of AEM's 132.37%. Michael Burry might see a serious short-term decline in relevance vs. the competitor.
No Data
No Data available this quarter, please select a different quarter.
1234.52%
5Y OCF/share CAGR is similar to AEM's 1256.32%. Walter Schloss might see parallel cost profiles or expansions producing comparable cash flow.
14311.97%
3Y OCF/share CAGR above 1.5x AEM's 2440.89%. David Dodd would confirm if the firm is quickly gaining an operational edge over the competitor.
No Data
No Data available this quarter, please select a different quarter.
26453.71%
5Y net income/share CAGR above 1.5x AEM's 7898.53%. David Dodd would confirm if the firm’s strategy is more effective in generating mid-term profits.
1590.09%
3Y net income/share CAGR above 1.5x AEM's 570.41%. David Dodd would confirm the company’s short-term strategies outmatch the competitor significantly.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
672.20%
3Y equity/share CAGR above 1.5x AEM's 76.43%. David Dodd verifies the company’s short-term capital management far exceeds the competitor’s pace.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
21.16%
AR growth is negative/stable vs. AEM's 120.02%, indicating tighter credit discipline. David Dodd confirms it doesn't hamper actual sales.
-28.98%
Both reduce inventory yoy. Martin Whitman suspects a broader move to lean operations or industry slowdown in demand.
117.23%
Asset growth above 1.5x AEM's 9.23%. David Dodd checks if M&A or new capacity expansions are value-accretive vs. competitor's approach.
50.21%
1.25-1.5x AEM's 35.21%. Bruce Berkowitz sees if the firm's capital management strategies surpass the competitor's approach.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-33.80%
We cut SG&A while AEM invests at 82.13%. Joel Greenblatt sees a short-term margin benefit but wonders if the competitor invests for future gains.